학술논문
[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].
Document Type
Academic Journal
Author
Orozco-Beltrán D; Medicina Familiar y Comunitaria, Unidad de Investigación Centro de Salud Cabo Huertas, Departamento San Juan de Alicante. Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan de Alicante, España. Electronic address: dorozcobeltran@gmail.com.; Brotons Cuixart C; Medicina Familiar y Comunitaria. Instituto de Investigación Biomédica (IIB) Sant Pau. Equipo de Atención Primaria Sardenya, Barcelona, España.; Banegas Banegas JR; Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España.; Gil Guillén VF; Medicina Familiar y Comunitaria, Hospital Universitario de Elda. Departamento de Medicina Clínica. Universidad Miguel Hernández, San Juan de Alicante, España.; Cebrián Cuenca AM; Medicina Familiar y Comunitaria, Centro de Salud Cartagena Casco Antiguo, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, España.; Martín Rioboó E; Medicina Familiar y Comunitaria, Especialista en Medicina Familiar y Comunitaria, Centro de Salud Poniente, Córdoba, IMIBIC Hospital Reina Sofía Córdoba. Colaborador del grupo PAPPS.; Jordá Baldó A; Medicina Familiar y Comunitaria, Centro de Salud San Miguel, Plasencia, Badajoz, España.; Vicuña J; Medicina Preventiva y Salud Pública, Hospital de la Sant Creu i Sant Pau, Barcelona, España.; Navarro Pérez J; Medicina Familiar y Comunitaria, Hospital Clínico Universitario. Departamento de Medicina. Universidad de Valencia. Instituto de Investigación INCLIVA, Valencia, España.
Source
Publisher: Elsevier España Country of Publication: Spain NLM ID: 9111075 Publication Model: Print Cited Medium: Internet ISSN: 1578-1275 (Electronic) Linking ISSN: 02126567 NLM ISO Abbreviation: Aten Primaria Subsets: MEDLINE
Subject
Language
Spanish; Castilian
Abstract
The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; cardiovascular (CV) risk and recommendations for the calculation of CV risk; main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation, and recommendations for management of chronic conditions. The quality of testing and the strength of the recommendation are included in the main recommendations.
(Copyright © 2022 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.)
(Copyright © 2022 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.)